DK0852232T3 - Cykliske peptidforbindelser til behandling af smerte og deres fremstillingsproces - Google Patents

Cykliske peptidforbindelser til behandling af smerte og deres fremstillingsproces

Info

Publication number
DK0852232T3
DK0852232T3 DK97309757T DK97309757T DK0852232T3 DK 0852232 T3 DK0852232 T3 DK 0852232T3 DK 97309757 T DK97309757 T DK 97309757T DK 97309757 T DK97309757 T DK 97309757T DK 0852232 T3 DK0852232 T3 DK 0852232T3
Authority
DK
Denmark
Prior art keywords
cyclic peptide
treatment
peptide compounds
pain
manufacturing process
Prior art date
Application number
DK97309757T
Other languages
Danish (da)
English (en)
Inventor
Nakao Kojima
Hiroyuki Nishida
Toshiyuki Saito
Nobuji Yoshikawa
Hideo Hirai
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0852232T3 publication Critical patent/DK0852232T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK97309757T 1996-12-04 1997-12-03 Cykliske peptidforbindelser til behandling af smerte og deres fremstillingsproces DK0852232T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB9601352 1996-12-04

Publications (1)

Publication Number Publication Date
DK0852232T3 true DK0852232T3 (da) 2002-04-22

Family

ID=11004499

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97309757T DK0852232T3 (da) 1996-12-04 1997-12-03 Cykliske peptidforbindelser til behandling af smerte og deres fremstillingsproces

Country Status (10)

Country Link
US (1) US5885959A (es)
EP (1) EP0852232B1 (es)
JP (1) JP3521110B2 (es)
AT (1) ATE211484T1 (es)
BR (1) BR9706222A (es)
CA (1) CA2223360C (es)
DE (1) DE69709841T2 (es)
DK (1) DK0852232T3 (es)
ES (1) ES2169325T3 (es)
MX (1) MX9709494A (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9709494A (es) * 1996-12-04 1998-07-31 Pfizer Compuestos peptidicos ciclicos, procedimiento para su produccion, composiciones que los contienen y uso de los mismos.
ES2338789T3 (es) 2003-06-18 2010-05-12 Tranzyme Pharma Inc. Antagonistas macrociclicos del receptor de motilina.
WO2016007956A2 (en) 2014-07-11 2016-01-14 University Of Kansas Cyclic tetrapeptide stereoisomers
ES2924903T3 (es) * 2017-01-20 2022-10-11 Univ Kansas Péptidos macrocíclicos para uso en el tratamiento de un cáncer de próstata o mama
AU2019239088A1 (en) 2018-03-23 2020-10-22 University Of Kansas Cyclic tetrapeptide analogs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0255224A3 (en) * 1986-06-30 1990-04-18 Merck & Co. Inc. Cyclic and bridged cyclic somatostatin analogs useful as analgesic agents
CA2090171A1 (en) * 1993-02-23 1994-08-24 Peter W. Schiller Opioid receptor antagonists, their synthesis and use as analgesic and immunosuppressive compounds
US5521156A (en) * 1994-02-03 1996-05-28 Merrell Pharmaceuticals Inc. Cyclic neurokinin A antagonists
IS4261A (is) * 1994-02-21 1995-08-22 Astra Aktiebolag Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra
MX9709494A (es) * 1996-12-04 1998-07-31 Pfizer Compuestos peptidicos ciclicos, procedimiento para su produccion, composiciones que los contienen y uso de los mismos.

Also Published As

Publication number Publication date
BR9706222A (pt) 1999-06-01
CA2223360A1 (en) 1998-06-04
JPH111492A (ja) 1999-01-06
CA2223360C (en) 2000-05-30
JP3521110B2 (ja) 2004-04-19
DE69709841T2 (de) 2002-08-22
DE69709841D1 (de) 2002-02-28
MX9709494A (es) 1998-07-31
US5885959A (en) 1999-03-23
EP0852232A1 (en) 1998-07-08
ATE211484T1 (de) 2002-01-15
EP0852232B1 (en) 2002-01-02
ES2169325T3 (es) 2002-07-01

Similar Documents

Publication Publication Date Title
DK0854874T3 (da) Makrocykliske lactonforbindelser og fremgangsmåde til fremstilling af disse
DK0723540T3 (da) Tricykliske amid- og urinstofderivater til inhibering af funktion af G-protein og til behandling af proliferative sygdomme
Ohfune et al. An efficient route to 1, 3-amino hydroxyl system via electrophilic lactonization of 2-amino-4-pentenoic acid derivatives. Stereoselective synthesis of (−)-bulgecinine
ATE217635T1 (de) Zyklische peptide mit antifungischer wirkung und verfahren zu ihrer herstellung
AU4624097A (en) Thio acid derived monocyclic (n)-heterocyclics as anticoagulants
SG43768A1 (en) Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative dieases
DE60229267D1 (de) Oxopyrrolidin verbindungen, verfahren zur herstellung dieser verbindungen und deren verwendung zur herstellung von levetiracetam und analogen
SE9904129D0 (sv) Novel compounds
DK0852232T3 (da) Cykliske peptidforbindelser til behandling af smerte og deres fremstillingsproces
IE882274L (en) Aralkylaminoalkoxyphenyl derivatives
HUP0204069A2 (hu) Új eljárás leflunomid előállítására és a leflunomid új kristályformája és ezt tartalmazó gyógyszerkészítmény
MY113863A (en) Method for preparing n, n' - disubstituted cyclic ureas
ATE166354T1 (de) Azabicycloarylacetylen- und arylenynoxine als cholinergische mittel und verfahren zur behandlung
NZ336793A (en) Method for stabilizing peptides by adding an organic acid and then lyophilizing the peptide mixture
BR9408223A (pt) Composto derivado de 4-benzoilisoxazol processo de preparação composição herbicida método de controle herbicida e compostos intermediarios
ATE11217T1 (de) Antibiotische substanzen, verfahren zu deren herstellung und deren zusammensetzungen; stamm von staphylococcus epidermidis, welcher diese antibiotische substanz produziert und deren zusammensetzungen.
EP0885891A4 (en) ISOXAZOLE DERIVATIVES
Matsunaga et al. Cribrochalinamine oxides A and B, antifungal β-substituted pyridines with an azomethine N-oxide from a marine sponge Cribrochalina sp.
EE05182B1 (et) Asendatud homopiperidlbensimidasooli analoog, meetod selle valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
EA200501734A1 (ru) Способ получения (4-гидрокси-6-оксотетрагидропиран-2-ил)ацетонитрила и его производных
ATE266652T1 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
EA199901059A1 (ru) Способ получения энантиомерно обогащенных n-производных лактамов
NO984206L (no) Fremgangsmaate for fremstilling av N-beskyttende D-prolinderivater
Bringmann A first biosynthetic proposal for the in vivo formation of naturally occurring diazepam-like 1, 4-benzodiazepines
Hasuoka et al. Synthesis and anti-Helicobacter pylori activity of pyloricidin derivatives II. The combination of amino acid residues in the dipeptidic moiety and its effect on the anti-Helicobacter pylori activity